Cargando…

The world of pulmonary vascular disease

Detalles Bibliográficos
Autores principales:	Yuan, Jason X.-J., Morrell, Nicholas W., Harikrishnan, S., Butrous, Ghazwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224421/ https://www.ncbi.nlm.nih.gov/pubmed/22140619 http://dx.doi.org/10.4103/2045-8932.87291

Ejemplares similares

Science is an endless frontier: Encouraging translational research in pulmonary vascular disease
por: Yuan, Jason X.-J., et al.
Publicado: (2012)

No doctor is an island
por: -J. Yuan, Jason X., et al.
Publicado: (2011)

Our journey continues
por: Yuan, Jason X.-J., et al.
Publicado: (2011)

A one-year-old baby… into the Year of the Dragon
por: Yuan, Jason X. -J., et al.
Publicado: (2012)

Pulmonary Circulation : A new venue for communicating your findings, ideas and perspectives
por: Yuan, Jason X.-J., et al.
Publicado: (2011)

Readership: The heart of Pulmonary Circulation
por: Yuan, Jason X.J., et al.
Publicado: (2013)

Saudi guidelines on the treatment and management of pulmonary hypertension 2014: Updates a fresh understanding of pulmonary vascular diseases in the developing world
por: Butrous, Ghazwan
Publicado: (2014)

The Pulmonary Vascular Research Institute celebrates its first decade
por: Yuan, Jason X.-J., et al.
Publicado: (2017)

Infection in pulmonary vascular diseases: Would another consortium really be the way to go?
por: Butrous, Ghazwan, et al.
Publicado: (2019)

The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases
por: Butrous, Ghazwan
Publicado: (2014)

International cooperation to promote advances in medicine
por: Butrous, Ghazwan
Publicado: (2008)

Pulmonary hypertension: From an orphan disease to a global epidemic
por: Butrous, Ghazwan
Publicado: (2020)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Schistosomiasis and pulmonary arterial hypertension
por: Butrous, Ghazwan
Publicado: (2014)

Schistosome infection and its effect on pulmonary circulation
por: Butrous, Ghazwan
Publicado: (2019)

The lamp of medicine of Ancient Egypt is still burning
por: Butrous, Ghazwan, et al.
Publicado: (2020)

Schistosomiasis causes remodeling of pulmonary vessels in the lung in a heterogeneous localized manner: Detailed study
por: Kolosionek, Ewa, et al.
Publicado: (2013)

Enhanced inflammatory cell profiles in schistosomiasis-induced pulmonary vascular remodeling
por: Ali, Zahara, et al.
Publicado: (2017)

Remembering Almaz Aldashev: one of the founders of the PVRI
por: Butrous, Ghazwan
Publicado: (2017)

Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells
por: Ali, Omar F, et al.
Publicado: (2011)

Pulmonary hypertension in the developing world: Local registries, challenges, and ways to move forward
por: Idrees, Majdy, et al.
Publicado: (2020)

Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease
por: Fraisse, Alain, et al.
Publicado: (2010)

Significant intrapulmonary Schistosoma egg antigens are not present in schistosomiasis-associated pulmonary hypertension
por: Graham, Brian B., et al.
Publicado: (2011)

mTORC1 in Pulmonary Arterial Hypertension. At the Crossroads between Vasoconstriction and Vascular Remodeling?
por: Goncharova, Elena A., et al.
Publicado: (2020)

Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype
por: Weatherald, Jason, et al.
Publicado: (2019)

Gut microbiota crosstalk mechanisms are key in pulmonary hypertension: The involvement of melatonin is instrumental too
por: Jacobs, Steve, et al.
Publicado: (2023)

Pulmonary hypertension and pulmonary vascular disease: course report
por: Peacock, Andrew, et al.
Publicado: (2018)

Pulmonary vascular disease for the general respiratory clinician
por: Kent, Brian D.
Publicado: (2022)

Smoking: Is it a risk factor for pulmonary vascular diseases?
por: Weissmann, Norbert, et al.
Publicado: (2012)

Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective
por: Halawa, Sarah, et al.
Publicado: (2021)

Revisiting the Role of KCNA5 in Pulmonary Arterial Hypertension
por: Ayon, Ramon J., et al.
Publicado: (2023)

Targeting ATP-Sensitive K(+) Channels to Treat Pulmonary Hypertension
por: Breen, Ellen, et al.
Publicado: (2022)

mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
por: Babicheva, Aleksandra, et al.
Publicado: (2021)

Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective
por: John Wort, S., et al.
Publicado: (2020)

Diagnosing heart failure with preserved ejection fraction with pulmonary vascular disease
por: Maeder, Micha T
Publicado: (2023)

The importance of the World Symposium on Pulmonary Hypertension
por: Jardim, Carlos, et al.
Publicado: (2018)

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
por: Harari, Sergio
Publicado: (2018)

NEDD9, a Hypoxia-upregulated Mediator for Pathogenic Platelet–Endothelial Cell Interaction in Pulmonary Hypertension
por: Wang, Jian, et al.
Publicado: (2021)

Vascular reperfusion in pulmonary thromboembolism: certainties and uncertainties
por: Amado, Veronica Moreira
Publicado: (2018)

Double Trouble: Airflow and Pulmonary Vascular Obstruction
por: Lee, Michael H., et al.
Publicado: (2021)

An overview of the 6th World Symposium on Pulmonary Hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rie8kkarbb0f59tkk74bcuajdb